A randomized, double-blind, placebo-controlled phase 1 and phase 2 clinical trial to evaluate efficacy and safety of a SARS-CoV-2 vaccine SCoK in adults.
Luo D, Pan H, He P, Yang X, Li T, Ning N, Fang X, Yu W, Wei M, Gao H, Wang X, Gu H, Mei M, Li X, Zhang L, Li D, Gao C, Gao J, Fei G, Li Y, Yang Y, Xu Y, Wei W, Sun Y, Zhu F, Hu Z, Wang H.
Luo D, et al. Among authors: wei m, wei w.
Clin Transl Med. 2022 Sep;12(9):e1016. doi: 10.1002/ctm2.1016.
Clin Transl Med. 2022.
PMID: 36103390
Free PMC article.
Clinical Trial.